米国企業
Jazz Pharmaceuticals plc

Jazz Pharmaceuticals plcJAZZ

時価総額

$68億

PER

16.4倍

	2011年 12月31日	2012年 12月31日	2013年 12月31日	2014年 12月31日	2015年 12月31日	2016年 12月31日	2017年 12月31日	2018年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日	2023年 12月31日
Cash and cash equivalents	82	387	637	684	989	366	386	310	637	1,058	591	881	1,506
Accounts Receivable, after Allowance for Credit Loss, Current	34	75	125	186	210	234	224	264	356	396	563	651	706
Investments	-	-	-	-	-	-	215	515	440	1,075	-	-	120
Inventories	4	27	29	30	19	34	43	53	79	95	1,073	714	597
Accounts Receivable, after Allowance for Credit Loss, Current	34	75	125	186	210	234	224	264	356	396	563	651	706
Prepaid expenses	2	7	7	13	21	25	23	25	39	62	131	92	185
Inventories	4	27	29	30	19	34	43	53	79	95	1,073	714	597
Other current assets	1	19	34	21	19	29	77	68	79	152	252	267	321
Prepaid expenses	2	7	7	13	21	25	23	25	39	62	131	92	185
Total current assets	199	552	865	1,016	1,258	748	968	1,234	1,630	2,840	2,611	2,606	3,435
Other current assets	1	19	34	21	19	29	77	68	79	152	252	267	321
Total current assets	199	552	865	1,016	1,258	748	968	1,234	1,630	2,840	2,611	2,606	3,435
Property, plant and equipment, net	-	-	-	-	-	-	-	-	-	-	257	228	170
Operating lease assets	-	-	-	-	-	-	-	-	139	129	87	73	65
Intangible assets, net	15	870	812	1,437	1,186	3,012	2,979	2,731	2,441	2,195	7,152	5,794	5,418
Goodwill	38	443	450	703	657	894	948	928	920	958	1,828	1,693	1,753
Deferred tax assets, net	-	-	-	-	-	15	35	58	221	255	311	376	478
Deferred financing costs	-	-	-	-	-	10	8	10	7	5	12	9	6
Other non-current assets	0	4	7	16	28	14	16	43	48	26	41	55	67
Total assets	254	1,966	2,238	3,339	3,360	4,800	5,124	5,203	5,539	6,536	12,299	10,835	11,393
Accounts payable	5	16	21	25	22	22	24	41	48	27	100	91	103
Accrued liabilities	35	105	120	164	164	193	199	265	268	353	666	803	794
Current portion of long-term debt	-	30	6	9	38	36	41	33	33	246	31	31	605
Income taxes payable	-	40	0	8	2	5	22	1	11	25	10	8	35
Deferred revenue	-	-	-	-	-	-	-	5	5	3	2	0	-
Total current liabilities	53	192	204	217	227	257	294	345	364	654	809	933	1,537
Deferred revenue, non-current	-	-	-	-	-	-	-	10	5	2	0	-	-
Long-term debt, less current portion	-	427	544	1,333	1,167	1,994	1,540	1,563	1,574	1,849	6,019	5,693	5,108
Long-term debt, less current portion	-	427	544	1,333	1,167	1,994	1,540	1,563	1,574	1,849	6,019	5,693	5,108
Operating Lease, Liability, Noncurrent	-	-	-	-	-	-	-	-	151	140	87	72	59
Operating Lease, Liability, Noncurrent	-	-	-	-	-	-	-	-	151	140	87	72	59
Deferred tax liabilities, net	-	-	-	-	-	557	383	309	224	130	1,301	944	848
Deferred tax liabilities, net	-	-	-	-	-	557	383	309	224	130	1,301	944	848
Other non-current liabilities	-	7	20	38	69	113	177	219	109	101	117	107	105
Other non-current liabilities	-	7	20	38	69	113	177	219	109	101	117	107	105
Common Stock, Value, Issued	0	0	0	0	0	0	0	0	0	0	0	0	0
Nonvoting Euro Deferred Shares	-	0	0	0	0	0	0	0	0	0	0	0	0
Capital redemption reserve	-	0	0	0	0	0	0	0	0	0	0	0	0
Additional paid-in capital	543	1,151	1,220	1,458	1,563	1,665	1,935	2,114	2,266	2,634	3,535	3,477	3,700
Accumulated other comprehensive loss	-	31	56	-122	-267	-317	-141	-198	-223	-134	-400	-1,126	-842
Retained earnings	-350	-61	19	35	303	529	918	841	1,068	1,160	830	734	879
Total shareholders’ equity	193	1,121	1,296	1,371	1,599	1,877	2,713	2,757	3,111	3,660	3,965	3,086	3,737
Common Stock, Value, Issued	0	0	0	0	0	0	0	0	0	0	0	0	0
Nonvoting Euro Deferred Shares	-	0	0	0	0	0	0	0	0	0	0	0	0
Capital redemption reserve	-	0	0	0	0	0	0	0	0	0	0	0	0
Additional paid-in capital	543	1,151	1,220	1,458	1,563	1,665	1,935	2,114	2,266	2,634	3,535	3,477	3,700
Accumulated other comprehensive loss	-	31	56	-122	-267	-317	-141	-198	-223	-134	-400	-1,126	-842
Retained earnings	-350	-61	19	35	303	529	918	841	1,068	1,160	830	734	879
Total shareholders’ equity	193	1,121	1,296	1,371	1,599	1,877	2,713	2,757	3,111	3,660	3,965	3,086	3,737
Total liabilities and shareholders’ equity	254	1,966	2,238	3,339	3,360	4,800	5,124	5,203	5,539	6,536	12,299	10,835	11,393
Total liabilities and shareholders’ equity	254	1,966	2,238	3,339	3,360	4,800	5,124	5,203	5,539	6,536	12,299	10,835	11,393